Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Astrid Reul
Observed name:
Reul, Astrid
Institutions:
University of Zurich,
University Hospital Zurich
Observed institutions:
University of Zurich,
University Hospital Zurich
OpenAlex ID:
A5079528827
Metastatic Pheochromocytoma and Paraganglioma: Somatostatin Receptor 2 Expression, Genetics, and Therapeutic Responses
2023
·
Alessa Fischer
, Simon Kloos
, et al.
·
The Journal of Clinical Endocrinology & Metabolism
·
50
PDF
Personalized drug testing in human pheochromocytoma/paraganglioma primary cultures
2022
·
Katharina Wang
, Ina Schütze
, et al.
·
Endocrine Related Cancer
·
32
PDF
Responses to systemic therapy in metastatic pheochromocytoma/paraganglioma: a retrospective multicenter cohort study
2023
·
Alessa Fischer
, Simon Kloos
, et al.
·
European Journal of Endocrinology
·
21
Proneuropeptide Y and neuropeptide Y metabolites in healthy volunteers and patients with a pheochromocytoma or paraganglioma
2022
·
Philippe J. Eugster
, Jonathan Maurer
, et al.
·
Clinica Chimica Acta
·
12
PDF
Opposing Effects of Cannabidiol in Patient-derived Neuroendocrine Tumor, Pheochromocytoma/Paraganglioma Primary Cultures
2024
·
Katharina Wang
, Laura Schober
, et al.
·
The Journal of Clinical Endocrinology & Metabolism
·
10
PDF
Impact of sex hormones on pheochromocytomas, paragangliomas, and gastroenteropancreatic neuroendocrine tumors
2025
·
Katharina Wang
, Alessa Fischer
, et al.
·
European Journal of Endocrinology
·
5
PD-L1 and HIF-2α Upregulation in Head and Neck Paragangliomas after Embolization
2023
·
Alessa Fischer
, Umberto Maccio
, et al.
·
Cancers
·
5
PDF
Impact of the PI3K-alpha inhibitor alpelisib on everolimus resistance and somatostatin receptor expression in an orthotopic pancreatic NEC xenograft mouse model
2023
·
Ajay-Mohan Mohan
, Sonal Prasad
, et al.
·
Endocrine Related Cancer
·
4
Paltusotine versus octreotide: different effects on radioligand uptake in neuroendocrine tumours
2025
·
Katharina Wang
, Christoph J Auernhammer
, et al.
·
Endocrine Oncology
·
2
Personalized Drug Screening and Risk Assessment in Patient-Derived Gastroenteropancreatic Neuroendocrine Neoplasms
2026
·
Christoph J Auernhammer
, Katharina Wang
, et al.
·
The Journal of Clinical Endocrinology & Metabolism
·
1
Supplementary data: Personalized drug screening and risk assessment in patient-derived gastroenteropancreatic neuroendocrine neoplasms
2025
·
Auernhammer, Christoph J
, Wang, Katharina
, et al.
·
Universitätsbibliothek der LMU
·
1
Effects of a GLP-1 agonist and anti-diabetic therapies on pheochromocytoma/paraganglioma growth
2026
·
Katharina Wang
, Priska Stempfle
, et al.
·
Endocrine Related Cancer
EP1108 - ECE_2149 - Nicotinamide phosphoribosyltransferase (NAMPT) inhibition—a novel metabolically-guided personalised therapy for neuroendocrine neoplasia
2026
·
Katharina Wang
, Julia Hamati
, et al.
·
European Journal of Endocrinology
PDF
A novel 2D and 3D model for primary adrenocortical carcinoma of advanced and metastasized stage co-secreting cortisol, aldosterone, testosterone, 18-oxocortisol and 18-hydroxycortisol
2026
·
Igor Shapiro
, Chiara Kräuchi
, et al.
·
Endocrine Related Cancer
Opposing effects of cannabidiol (CBD) on pheochromocytoma/paraganglioma and neuroendocrine tumor cell lines and individual patient-derived primary cultures
2024
·
Katharina Wang
, Laura Schober
, et al.
·
Endocrine Abstracts
Show more works
View as search
Works count:
17
Citation count:
144
H-index:
5
I10-index:
5
Year
Topic
Type
